Description
NVP-AUY922isanisoxazole-basedinhibitorofheatshockprotein90(HSP90)thatdisplaysanticancerchemotherapeuticandanti-angiogenicactivities.NVP-AUY922inhibitscellgrowthinpancreaticandcolorectalcancercells.InadultT-cellleukemiacells,NVP-AUY922inducesG1phasecellcyclearrestandapoptosis,suppressingcellgrowth.Additionally,thiscompoundinducestumorregressionanddecreasesmicrovesseldensityinanimalmodelsofbreastcancer,ovariancancer,prostatecancer,andmelanoma.
References
KimSH,KangJG,KimCS,etal.NovelHeatShockProtein90InhibitorNVP-AUY922SynergizesWiththeHistoneDeacetylaseInhibitorPXD101inInductionofDeathofAnaplasticThyroidCarcinomaCells.JClinEndocrinolMetab.2015Feb;100(2):E253-61.PMID:25389633.
TaniguchiH,HasegawaH,SasakiD,etal.Heatshockprotein90inhibitorNVP-AUY922exertspotentactivityagainstadultT-cellleukemia-lymphomacells.CancerSci.2014Dec;105(12):1601-8.PMID:25263741.
EcclesSA,MasseyA,RaynaudFI,etal.NVP-AUY922:anovelheatshockprotein90inhibitoractiveagainstxenografttumorgrowth,angiogenesis,andmetastasis.CancerRes.2008Apr15;68(8):2850-60.PMID:18413753.